搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Clostridium perfringens Queuine tRNA-ribosyltransferase (tgt) CSB-YP611659CAAN
CSB-EP611659CAAN
CSB-BP611659CAAN
CSB-MP611659CAAN
CSB-EP611659CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Dihydrodipicolinate synthase (dapA) CSB-YP611660CAAN
CSB-EP611660CAAN
CSB-BP611660CAAN
CSB-MP611660CAAN
CSB-EP611660CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens 50S ribosomal protein L20 (rplT) CSB-YP611661CAAN
CSB-EP611661CAAN
CSB-BP611661CAAN
CSB-MP611661CAAN
CSB-EP611661CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Elongation factor P (efp) CSB-YP611662CAAN
CSB-EP611662CAAN
CSB-BP611662CAAN
CSB-MP611662CAAN
CSB-EP611662CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP611663CAAN
CSB-EP611663CAAN
CSB-BP611663CAAN
CSB-MP611663CAAN
CSB-EP611663CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Molybdenum cofactor biosynthesis protein A (moaA) CSB-YP611664CAAN
CSB-EP611664CAAN
CSB-BP611664CAAN
CSB-MP611664CAAN
CSB-EP611664CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Putative Holliday junction resolvase (CPF_2031) CSB-YP611665CAAN
CSB-EP611665CAAN
CSB-BP611665CAAN
CSB-MP611665CAAN
CSB-EP611665CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP611666CAAN
CSB-EP611666CAAN
CSB-BP611666CAAN
CSB-MP611666CAAN
CSB-EP611666CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Acyl carrier protein (acpP) CSB-YP611667CAAN
CSB-EP611667CAAN
CSB-BP611667CAAN
CSB-MP611667CAAN
CSB-EP611667CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Ribosome-recycling factor (frr) CSB-YP611668CAAN
CSB-EP611668CAAN
CSB-BP611668CAAN
CSB-MP611668CAAN
CSB-EP611668CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens D-ribose pyranase (rbsD) CSB-YP611669CAAN
CSB-EP611669CAAN
CSB-BP611669CAAN
CSB-MP611669CAAN
CSB-EP611669CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens DNA polymerase IV (dinB) CSB-YP611670CAAN
CSB-EP611670CAAN
CSB-BP611670CAAN
CSB-MP611670CAAN
CSB-EP611670CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP611671CAAN
CSB-EP611671CAAN
CSB-BP611671CAAN
CSB-MP611671CAAN
CSB-EP611671CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Galactokinase (galK) CSB-YP611672CAAN
CSB-EP611672CAAN
CSB-BP611672CAAN
CSB-MP611672CAAN
CSB-EP611672CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Phosphoglycerate kinase (pgk) CSB-YP611673CAAN
CSB-EP611673CAAN
CSB-BP611673CAAN
CSB-MP611673CAAN
CSB-EP611673CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Putative cobalt-precorrin-6A synthase [deacetylating] (cbiD) CSB-YP611674CAAN
CSB-EP611674CAAN
CSB-BP611674CAAN
CSB-MP611674CAAN
CSB-EP611674CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP611675CAAN
CSB-EP611675CAAN
CSB-BP611675CAAN
CSB-MP611675CAAN
CSB-EP611675CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Cytidylate kinase (cmk) CSB-YP611676CAAN
CSB-EP611676CAAN
CSB-BP611676CAAN
CSB-MP611676CAAN
CSB-EP611676CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens Potassium-transporting ATPase C chain (kdpC), partial CSB-YP611677CAAN
CSB-EP611677CAAN
CSB-BP611677CAAN
CSB-MP611677CAAN
CSB-EP611677CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium perfringens UPF0145 protein CPF_0876 (CPF_0876) CSB-YP611678CAAN
CSB-EP611678CAAN
CSB-BP611678CAAN
CSB-MP611678CAAN
CSB-EP611678CAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>